
Tetrahedron p. 3593 - 3608 (1996)
Update date:2022-07-29
Topics:
Zegelaar-Jaarsveld, Korien
Smits, Sander A. W.
Van Straten, Nicole C. R.
Van Der Marel, Gijs A.
Van Boom, Jacques H.
Two procedures are described towards the assembly of the tyramine spacer-containing tetramer 5, a derivative of the phenolic glycolipid of Mycobacterium kansasii serovar I. First, iodonium ion-mediated glycosylation of trimeric acceptor 2a with D-rhamnopyranoside donor 10 gave fully protected tetramer 17. Selective removal of the chloroacetyl group of 17, subsequent deoxygenation and removal of the protective groups, led to target 5. The potential occurrence of double stereodifferentiation (DSD) was examined by condensation of L-fucopyranoside model acceptor 14 with both the enantiomeric rhamnopyranoside donors 10 and 13. The second procedure involves elongation of trimeric acceptor 2b with 6-deoxy-D-glucopyranoside 28. Desulfurisation of the resulting tetrameric fragment 36 followed by hydrogenation of 37 gave 38, the phenylacetyl (PhAc) of which was enzymatically removed to yield target tetramer 5.
View MoreMollt Biochem Co., Ltd(expird)
Contact:+86-21-38682181
Address:shanghai ,china
shijiazhuang shuanglian chemical industry co.,ltd
Contact:0311-82190302
Address:Luquan Intersection , Shijiazhuang--Taiyuan Expressway,Shijiazhuang City
Contact:86-25-84683399
Address:605, Phoenix Herui Plaza, No.389, South Taiping Road, Nanjing, China 210002
Contact:+86-021-6989-5597
Address:No.80 Yichuan Rd., Putuo District,Shanghai,P.R.China
Nanjing Zelang Medical Technology Co. Ltd
Contact:86-25-83063290/13770714480
Address:Ganjiabian 108# 01 Unit,701-702 room,Yao Hua Street,Qixia District,Nanjing,Jiangsu,China
Doi:10.1016/0040-4039(96)00226-2
(1996)Doi:10.1007/BF00601112
()Doi:10.1016/0040-4039(96)00239-0
(1996)Doi:10.1039/cc9960000869
(1996)Doi:10.1039/b008232p
(2001)Doi:10.1016/S0957-4166(00)00464-X
(2000)